Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Campylobacter, Salmonella, Shigella and STEC

Infectious diseases, microbiology and sexual health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Dysentery with sepsis, HUS or abdominal complication

Shock, peritonism, toxic megacolon, severe immunosuppression, persistent bacteraemia, neurological change or bloody diarrhoea followed by anaemia, thrombocytopenia and renal injury requires emergency care.

Action: Use ABCDE, begin isolation and rehydration, send stool and blood specimens urgently, avoid antibiotics and antimotility drugs when STEC is plausible, and involve infection, renal, gastroenterology, surgical or critical-care teams according to the syndrome.

Synopsis

Distinguish four major bacterial diarrhoeal syndromes, recognise invasive and toxin-mediated complications, select public-health testing and use antimicrobials only where benefit outweighs organism-specific harm.

  • Campylobacter commonly causes fever, cramping and sometimes bloody diarrhoea after poultry, unpasteurised milk, animal or water exposure; most cases need fluids only.
  • Non-typhoidal Salmonella usually produces self-limiting gastroenteritis after food or animal exposure, but bacteraemia can seed arteries, bone and prostheses.
  • Shigella has a very low infectious dose and causes fever, cramps, tenesmus and small-volume bloody or mucoid stool with important person-to-person spread.
  • STEC produces severe cramping and bloody diarrhoea, often with little fever; antibiotics and antimotility drugs may increase toxin exposure and are avoided.
  • Send stool culture or PCR in bloody, severe or outbreak-associated disease and ensure culture and susceptibility follow molecular detection when required.
  • Take blood cultures for sepsis, enteric fever differential, immunosuppression or suspected invasive Salmonella disease.
  • Antibiotics are not routine for Campylobacter or uncomplicated non-typhoidal Salmonella; selected severe or high-risk disease is treated from susceptibility and local guidance.
  • Notify and coordinate with the health-protection team for STEC, Shigella, outbreaks and occupational or institutional transmission concerns.

Key red flags

Bloody diarrhoea with falling platelets, fragmented red cells or rising creatinine suggests STEC-associated haemolytic uraemic syndrome.

Severe abdominal tenderness, guarding, distension or absent bowel sounds indicates possible perforation, ischaemia or toxic megacolon.

Persistent non-typhoidal Salmonella bacteraemia with back, abdominal or chest pain suggests infected arterial tissue or vascular graft.

Shigellosis in a sexual network or after international travel may be extensively drug resistant and needs susceptibility-led treatment.

Campylobacter illness followed by ascending weakness, areflexia, facial weakness or breathing difficulty suggests Guillain–Barré syndrome.

Any invasive disease in pregnancy, older age, immunosuppression, haemoglobinopathy or major vascular disease needs early specialist review.

Shigella dysentery

Fever, urgency, tenesmus and frequent small-volume stool containing blood or mucus suggest invasive distal colitis and easy transmission.

STEC syndrome

Severe abdominal cramps and bloody diarrhoea with limited fever after farm, animal, food or linked-case exposure raises toxin-mediated risk.

Invasive Salmonella

Persistent fever, positive blood cultures, focal bone pain or aortic-region pain indicates extra-intestinal infection requiring imaging and prolonged treatment.

Post-infectious complication

Investigation priorities

01
Stool PCR and cultureFirst step

Detect Campylobacter, Salmonella, Shigella and Shiga toxin genes and preserve isolates for susceptibility and public-health typing.

Management branches

BLOODProtect against STEC harm

An adult has bloody diarrhoea, severe cramping or epidemiological exposure compatible with STEC.

  1. Isolate, rehydrate and send urgent stool testing that includes Shiga toxin detection and culture.
  2. Avoid antibiotics and antimotility drugs until STEC is excluded or a specialist identifies a compelling alternative indication.
  3. Obtain baseline and serial full blood count, platelets, creatinine, blood film and haemolysis markers according to severity.
  4. Escalate falling platelets, haemolysis, reduced urine or neurological change to renal and critical-care teams immediately.

Key medicines

Azithromycin for selected CampylobacterGive 500 mg orally once daily for three days when severe or prolonged Campylobacter disease or host risk justifies treatment and local guidance supports macrolide therapy.Check QT risk, liver disease, pregnancy context, interactions and local resistance; most uncomplicated cases do not need an antimicrobial.
Ceftriaxone for susceptible invasive SalmonellaGive 2 g intravenously once daily for susceptible invasive non-typhoidal Salmonella when selected by infection specialists; duration depends on bloodstream clearance and seeded focus.Review allergy, biliary adverse effects, renal and liver context and culture susceptibility; arterial or prosthetic infection requires source control and a longer course.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • UKHSA Campylobacter: guidance, data and analysis
  • UKHSA Salmonella: guidance, data and analysis
  • UKHSA Shigella: guidance, data and analysis
  • UKHSA Escherichia coli: guidance, data and analysis

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom

Weakness after Campylobacter or arthritis after Campylobacter, Salmonella or Shigella may begin after bowel symptoms improve.